CrowdStrike To Rally More Than 16%? Here Are 10 Top Analyst Forecasts For Monday
Portfolio Pulse from Lisa Levin
Wall Street analysts have updated their price targets and ratings for several companies. Keybanc raised Synopsys' target to $600, maintaining an Overweight rating. Berenberg downgraded Corteva to Hold, reducing the target to $52. UBS upgraded Teva Pharmaceutical to Buy, increasing the target to $13. Morgan Stanley downgraded Southern Copper to Underweight, cutting the target to $68. Deutsche Bank downgraded Canadian Pacific Kansas City and Old Dominion Freight Line to Hold, with reduced targets of $77 and $386, respectively. UBS downgraded GE HealthCare to Sell, slashing the target to $66. Needham raised CrowdStrike's target to $245, maintaining a Buy rating. JP Morgan downgraded Afya to Neutral, with a target of $23. Keybanc reduced IAC's target to $68 but kept an Overweight rating.
November 27, 2023 | 12:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham raised CrowdStrike's price target from $215 to $245, maintaining a Buy rating.
The increased price target and continued Buy rating by Needham indicate a positive outlook, which could lead to a rise in CrowdStrike's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Keybanc raised Synopsys' price target from $540 to $600 and maintained an Overweight rating.
The increase in price target and the maintenance of an Overweight rating by Keybanc could lead to a positive short-term impact on Synopsys' stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
UBS upgraded Teva Pharmaceutical to Buy from Neutral and increased the price target from $11 to $13.
UBS's upgrade to Buy and the raised price target suggest a bullish outlook, which could positively impact Teva Pharmaceutical's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEUTRAL IMPACT
JP Morgan downgraded Afya to Neutral from Overweight and increased the price target from $22 to $23.
JP Morgan's downgrade to Neutral, despite a slight increase in price target, presents mixed signals, likely resulting in a neutral short-term impact on Afya's stock.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEUTRAL IMPACT
Keybanc reduced IAC's price target from $72 to $68 but maintained an Overweight rating.
Keybanc's reduction in IAC's price target, while still maintaining an Overweight rating, could have a neutral short-term impact on the stock.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Deutsche Bank downgraded Canadian Pacific Kansas City to Hold and slashed the price target from $85 to $77.
The downgrade to Hold and the significant cut in price target by Deutsche Bank could have a bearish short-term effect on Canadian Pacific Kansas City's stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Berenberg downgraded Corteva to Hold and cut the price target from $63 to $52.
The downgrade to Hold and reduction in price target by Berenberg could negatively affect Corteva's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
UBS downgraded GE HealthCare to Sell from Neutral and cut the price target from $86 to $66.
The downgrade to Sell and the reduced price target by UBS could result in a negative short-term impact on GE HealthCare's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Deutsche Bank downgraded Old Dominion Freight Line to Hold and reduced the price target from $475 to $386.
The downgrade to Hold and the decrease in price target by Deutsche Bank could negatively influence Old Dominion Freight Line's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Morgan Stanley downgraded Southern Copper to Underweight and reduced the price target from $83 to $68.
The downgrade to Underweight and the lowered price target by Morgan Stanley could lead to a negative short-term impact on Southern Copper's stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90